Literature DB >> 2323061

Characterization of a monoclonal antibody specific for prostatic secretory protein of 94 amino acids (PSP94) and development of a two-site binding enzyme immunoassay for PSP94.

H von der Kammer1, E Krauhs, G Aumüller, K H Scheit.   

Abstract

Purified prostatic secretory protein of 94 amino acids (PSP94) was used to generate polyclonal rabbit anti-PSP94 IgG and a murine monoclonal antibody 6B6 (mAB6B6). Both antibodies were highly specific for PSP94 by immunoblotting. Immunohistochemical studies demonstrated the specificity of mAB6B6 for human prostatic epithelial tissue. A two-site binding enzyme immunoassay for the detection of PSP94 was developed using a combination of the antibodies. The sandwich-ELISA yielded satisfactory results when mAB6B6 complexed to peroxidase conjugated goat anti-mouse-IgG (Fc) was incubated simultaneously with the sample. The assay has a dynamic range of 2-30 micrograms/l. This immunoassay was employed to measure PSP94 in male human sera (8 +/- 4 micrograms/l), female human sera (5.7 +/- 3.4 micrograms/l), follicular fluid (3.9 +/- 2.9 micrograms/l) and human seminal plasma (1.02 +/- 0.8 g/l).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323061     DOI: 10.1016/0009-8981(90)90106-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  The evaluation of markers of prostatic function.

Authors:  H von der Kammer; K H Scheit; W Weidner; T G Cooper
Journal:  Urol Res       Date:  1991

2.  The potential use of prostatic secretory protein of 94 amino acid residues (PSP94) as a serum marker for prostatic tumor.

Authors:  H von der Kammer; C Jurincic-Winkler; R Horlbeck; K F Klippel; H U Pixberg; K H Scheit
Journal:  Urol Res       Date:  1993-05

3.  Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients.

Authors:  T J Babineau; P Marcello; W Swails; A Kenler; B Bistrian; R A Forse
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

4.  Identification, purification and characterization of a novel human blood protein with binding affinity for prostate secretory protein of 94 amino acids.

Authors:  Jonathan R Reeves; Jim W Xuan; Katerina Arfanis; Catherine Morin; Seema V Garde; Marcia T Ruiz; Jan Wisniewski; Chandra Panchal; Jerome E Tanner
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

5.  The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.

Authors:  Hayley C Whitaker; Zsofia Kote-Jarai; Helen Ross-Adams; Anne Y Warren; Johanna Burge; Anne George; Elizabeth Bancroft; Sameer Jhavar; Daniel Leongamornlert; Malgorzata Tymrakiewicz; Edward Saunders; Elizabeth Page; Anita Mitra; Gillian Mitchell; Geoffrey J Lindeman; D Gareth Evans; Ignacio Blanco; Catherine Mercer; Wendy S Rubinstein; Virginia Clowes; Fiona Douglas; Shirley Hodgson; Lisa Walker; Alan Donaldson; Louise Izatt; Huw Dorkins; Alison Male; Kathy Tucker; Alan Stapleton; Jimmy Lam; Judy Kirk; Hans Lilja; Douglas Easton; Colin Cooper; Rosalind Eeles; David E Neal
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.